Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial

NARecruitingINTERVENTIONAL
Enrollment

454

Participants

Timeline

Start Date

June 29, 2023

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2027

Conditions
PreeclampsiaHypertensive Disorder of PregnancyToxemiaPregnancy ComplicationsHypertension, Pregnancy-InducedHypertensionObesityOverweightNutrition DisordersVascular DiseasesCardiovascular DiseasesPre-EclampsiaEclampsiaGestational Hypertension
Interventions
BEHAVIORAL

Heart Health Doula Intervention Program

The intervention group will be given a smart blood pressure cuff and a smart scale to monitor weight. The intervention group will receive support provided a postpartum doula until 8-12 weeks postpartum. The doula will provide individualized support during this time, and after 8-12 weeks, women will transition to a doula-moderated support group for the remainder of the study. The intervention group will continue to receive blood pressure and weight monitoring for the remainder of the study.

BEHAVIORAL

Usual Care

Usual care includes enrollment into a clinical 6-week home-based blood pressure monitoring program with text messaging support which includes receiving a home blood pressure cuff. Women in the intervention group will be offered the same support as the usual care group, and in addition will receive the intervention and supplies.

Trial Locations (1)

15213

RECRUITING

Magee Women's Hospital of UPMC, Pittsburgh

All Listed Sponsors
collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

lead

University of Pittsburgh

OTHER